• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Malignancy Risk Assessment of Cytologically Indeterminate Thyroid Nodules Improves Markedly by Using a Predictive Model.使用预测模型可显著改善甲状腺细胞学检查结果不确定结节的恶性风险评估。
Eur Thyroid J. 2019 Apr;8(2):83-89. doi: 10.1159/000494720. Epub 2018 Nov 29.
2
The role of thyroid sonographic malignancy risk features when the fine needle aspiration biopsy result is indeterminate.当细针穿刺活检结果不确定时,甲状腺超声恶性风险特征的作用。
Endokrynol Pol. 2022;73(2):316-324. doi: 10.5603/EP.a2022.0027.
3
Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis.核异型性在细胞学不确定的甲状腺结节中与癌症风险的相关性:系统评价和荟萃分析。
Thyroid. 2018 Feb;28(2):210-219. doi: 10.1089/thy.2017.0419. Epub 2017 Dec 21.
4
Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.超声特征与细胞学不确定的甲状腺结节中的恶性肿瘤相关。
Eur J Surg Oncol. 2014 Feb;40(2):182-6. doi: 10.1016/j.ejso.2013.11.015. Epub 2013 Dec 14.
5
Differences in Thyroid Nodule Cytology and Malignancy Risk Between Children and Adults.儿童与成人甲状腺结节细胞学检查与恶变风险的差异。
Thyroid. 2019 Aug;29(8):1097-1104. doi: 10.1089/thy.2018.0728.
6
Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.根据核和结构异型性对 Bethesda 不典型和滤泡性肿瘤类别的细分可提高甲状腺恶性风险的鉴别能力。
Thyroid. 2018 Apr;28(4):511-521. doi: 10.1089/thy.2017.0274. Epub 2018 Mar 29.
7
USING THE ATA AND ACR TI-RADS SONOGRAPHIC CLASSIFICATIONS AS ADJUNCTIVE PREDICTORS OF MALIGNANCY FOR INDETERMINATE THYROID NODULES.使用美国甲状腺协会和 ACR 甲状腺影像报告和数据系统超声分类作为不确定甲状腺结节恶性肿瘤的辅助预测因子。
Endocr Pract. 2019 Sep;25(9):908-917. doi: 10.4158/EP-2018-0559. Epub 2019 Jun 6.
8
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.ACR TI-RADS 与 ATA US 评分有助于对具有不确定细胞学特征的甲状腺结节进行管理。
BMC Endocr Disord. 2019 Oct 29;19(1):112. doi: 10.1186/s12902-019-0429-5.
9
Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison.在阿联酋,超声引导下细针穿刺细胞学检查和甲状腺结节超声检查的比较。
PLoS One. 2021 Apr 7;16(4):e0247807. doi: 10.1371/journal.pone.0247807. eCollection 2021.
10
Clinical and ultrasonographic features in cancer risk stratification of indeterminate thyroid nodules.临床和超声特征在不确定甲状腺结节的癌症风险分层中的作用。
Saudi Med J. 2022 May;43(5):473-478. doi: 10.15537/smj.2022.43.5.20220045.

引用本文的文献

1
Assisting clinical diagnosis with interpretable fuzzy probabilistic modelling.利用可解释的模糊概率模型辅助临床诊断。
BMC Med Inform Decis Mak. 2025 Sep 15;25(Suppl 3):330. doi: 10.1186/s12911-025-03183-5.
2
Integrated intraoperative predictive model for malignancy risk assessment of thyroid nodules with atypia of undetermined significance cytology.用于具有意义不明确的非典型性甲状腺结节恶性风险评估的术中综合预测模型
Sci Rep. 2025 Jan 13;15(1):1860. doi: 10.1038/s41598-024-84716-2.
3
The Impact of Mutation Allele Frequency on the Histopathological Characteristics of Thyroid Cancer.突变等位基因频率对甲状腺癌组织病理学特征的影响
Cancers (Basel). 2023 Dec 25;16(1):113. doi: 10.3390/cancers16010113.
4
Managing Bethesda IV thyroid nodules in an iodine-deficient population.在碘缺乏人群中处理贝塞斯达IV类甲状腺结节。
Gland Surg. 2023 Oct 30;12(10):1332-1335. doi: 10.21037/gs-23-361. Epub 2023 Oct 9.
5
Improving the TIR3B oncological stratification: try to bridge the gap through a comprehensive presurgical algorithm.改善 TIR3B 的肿瘤学分层:尝试通过综合术前算法来缩小差距。
J Endocrinol Invest. 2024 Mar;47(3):633-643. doi: 10.1007/s40618-023-02182-5. Epub 2023 Sep 22.
6
Ultrasound Parameters Can Accurately Predict the Risk of Malignancy in Patients with "Indeterminate TIR3b" Cytology Nodules: A Prospective Study.超声参数可准确预测“不确定 TIR3b”细胞学结节患者的恶性风险:一项前瞻性研究。
Int J Mol Sci. 2023 May 5;24(9):8296. doi: 10.3390/ijms24098296.
7
Coexisting Molecular Alterations Increase the Risk of Malignancy in Thyroid Nodules with Copy Number Alterations.共存的分子改变增加了具有拷贝数改变的甲状腺结节发生恶性肿瘤的风险。
Cancers (Basel). 2022 Dec 13;14(24):6149. doi: 10.3390/cancers14246149.
8
Identification of potential diagnostic and prognostic biomarkers for papillary thyroid microcarcinoma (PTMC) based on TMT-labeled LC-MS/MS and machine learning.基于 TMT 标记 LC-MS/MS 和机器学习鉴定甲状腺微小乳头状癌(PTMC)的潜在诊断和预后生物标志物。
J Endocrinol Invest. 2023 Jun;46(6):1131-1143. doi: 10.1007/s40618-022-01960-x. Epub 2022 Nov 23.
9
Value of transrectal contrast-enhanced ultrasound with clinical indicators in the prediction of bone metastasis in prostate cancer.经直肠超声造影联合临床指标在预测前列腺癌骨转移中的价值
Quant Imaging Med Surg. 2022 Mar;12(3):1750-1761. doi: 10.21037/qims-21-365.
10
Prevalence of thyroid carcinoma in nodules with thy 3 cytology: the role of preoperative ultrasonography and strain elastography.甲状腺细针穿刺结果为Thy 3的结节中甲状腺癌的患病率:术前超声检查和应变弹性成像的作用
Thyroid Res. 2021 Apr 9;14(1):7. doi: 10.1186/s13044-021-00098-x.

本文引用的文献

1
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
2
RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAFV600E Mutation-Negative Nodules?AUS/FLUS细胞学中的RAS突变:它在BRAFV600E突变阴性结节中是否具有额外作用?
Medicine (Baltimore). 2015 Jul;94(27):e1084. doi: 10.1097/MD.0000000000001084.
3
Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation.预测表和列线图作为诊断甲状腺乳头状癌的工具:超声检查、细针穿刺活检和BRAF V600E突变的联合分析
Medicine (Baltimore). 2015 May;94(21):e760. doi: 10.1097/MD.0000000000000760.
4
Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies.甲状腺超声特征与癌风险:观察性研究的系统评价和荟萃分析
Thyroid. 2015 May;25(5):538-50. doi: 10.1089/thy.2014.0353. Epub 2015 Mar 31.
5
Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology.甲状腺细胞病理学中意义不明确的非典型病变相关的恶性风险及可重复性。
Surgery. 2014 Dec;156(6):1471-6; discussion1476. doi: 10.1016/j.surg.2014.08.026. Epub 2014 Sep 11.
6
The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.意义不明确的非典型性/滤泡性病变及重复细针穿刺活检的影响:贝塞斯达系统实施前后5年
Cancer Cytopathol. 2014 Dec;122(12):866-72. doi: 10.1002/cncy.21468. Epub 2014 Jul 30.
7
Can ultrasound be used to predict malignancy in patients with a thyroid nodule and an indeterminate fine-needle aspiration biopsy?超声能否用于预测甲状腺结节伴细针抽吸活检不确定的患者的恶性肿瘤?
Surgery. 2014 Oct;156(4):967-70. doi: 10.1016/j.surg.2014.06.043. Epub 2014 Jul 26.
8
A nomogram for predicting malignancy in thyroid nodules diagnosed as atypia of undetermined significance/follicular lesions of undetermined significance on fine needle aspiration.用于预测在细针抽吸诊断为不明确意义的甲状腺结节/不明确意义的滤泡性病变的不典型性中的恶性肿瘤的列线图。
Surgery. 2014 Jun;155(6):1006-13. doi: 10.1016/j.surg.2013.12.035. Epub 2014 Jan 3.
9
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).甲状腺结节分类为贝塞斯达Ⅲ类(不典型/意义未明的滤泡性病变)的恶性率。
Thyroid. 2014 May;24(5):832-9. doi: 10.1089/thy.2013.0317. Epub 2014 Mar 10.
10
The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis.甲状腺结节超声检查对甲状腺癌的预测准确性:系统评价和荟萃分析。
J Clin Endocrinol Metab. 2014 Apr;99(4):1253-63. doi: 10.1210/jc.2013-2928. Epub 2013 Nov 25.

使用预测模型可显著改善甲状腺细胞学检查结果不确定结节的恶性风险评估。

The Malignancy Risk Assessment of Cytologically Indeterminate Thyroid Nodules Improves Markedly by Using a Predictive Model.

作者信息

Öcal Bülent, Korkmaz Mehmet Hakan, Yılmazer Demet, Taşkın Türkmenoğlu Tuğba, Bayır Ömer, Saylam Güleser, Çadallı Tatar Emel, Karahan Sevilay, Çakal Erman

机构信息

Department of Otolaryngology, Ministry of Health Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.

Department of Otolaryngology, Yıldırım Beyazıt University Medical School, Ankara, Turkey.

出版信息

Eur Thyroid J. 2019 Apr;8(2):83-89. doi: 10.1159/000494720. Epub 2018 Nov 29.

DOI:10.1159/000494720
PMID:31192147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6514482/
Abstract

OBJECTIVES

The majority of thyroid nodules are discovered incidentally, and the management may be a challenge if the fine needle aspiration specimen yields indeterminate findings. Our aim was to develop an individualized risk prediction model to provide an accurate estimate of cancer risk in patients with cytologically indeterminate thyroid nodules.

MATERIALS AND METHODS

Clinical records, ultrasound images, and cytopathology reports of patients who underwent thyroidectomy were retrospectively reviewed. Logistic regression analysis was used to identify the predictive ability of each variable for malignancy, and a nomogram was built by integrating patients' age, multiplicity of nodules, cytology results, and suspicious ultrasound features, such as microcalcifications and irregular margins.

RESULTS

For the 233 indeterminate nodules according to the Bethesda System for Reporting Thyroid Cytopathology, the malignancy rates of the subgroups "atypia of undetermined significance," "suspicious follicular neoplasia," and "suspicious for malignancy" were 44.3, 47.7, and 88.0%, respectively. It was found that the Bethesda category "suspicious for malignancy," microcalcifications, and irregular margins were independent risk factors for malignancy. The area under the receiver operating characteristics curve was 0.784, which suggested that the presented nomogram had considerable discriminative performance.

CONCLUSIONS

The nomogram developed in our study accurately predicts the malignancy risk of thyroid nodules with indeterminate cytology by using clinical, cytological, and ultrasonographic features.

摘要

目的

大多数甲状腺结节是偶然发现的,如果细针穿刺标本结果不确定,其处理可能具有挑战性。我们的目的是开发一种个体化风险预测模型,以准确估计甲状腺细针穿刺结果不确定患者的癌症风险。

材料与方法

对接受甲状腺切除术患者的临床记录、超声图像和细胞病理学报告进行回顾性分析。采用逻辑回归分析确定各变量对恶性肿瘤的预测能力,并通过整合患者年龄、结节数量、细胞学结果以及可疑超声特征(如微钙化和边缘不规则)构建列线图。

结果

根据甲状腺细胞病理学报告的贝塞斯达系统,233个不确定结节中,“意义不明确的非典型病变”“可疑滤泡性肿瘤”和“可疑恶性肿瘤”亚组的恶性率分别为44.3%、47.7%和88.0%。发现贝塞斯达分类“可疑恶性肿瘤”、微钙化和边缘不规则是恶性肿瘤的独立危险因素。受试者工作特征曲线下面积为0.784,表明所构建的列线图具有相当的鉴别性能。

结论

我们研究中开发的列线图通过使用临床、细胞学和超声特征,准确预测了甲状腺细针穿刺结果不确定结节的恶性风险。